Task: Answer the following question about the molecule with SMILES CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1.
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Answer: Phase 2 Clinical Trials
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1
CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1
4-(2-ethyl-5-fluoranyl-1,3-dihydroinden-2-yl)-1H-imidazole
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.